Renal Profile of Patients with Cardiorenal Syndrome: Nephrology and Cardiology Department Experience of the IBN SINA University Hospital of Rabat — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Renal Profile of Patients with Cardiorenal Syndrome: Nephrology and Cardiology Department Experience of the IBN SINA University Hospital of Rabat
Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
,
Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
,
Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
,
Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
,
Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
,
Laboratory of Biostatistics, Clinical Research and Epidemiology, Department of Public Health, Mohamed V University, Rabat, Morocco
,
Department of Cardiology B, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
,
Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
1 Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
2 Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
3 Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
4 Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
5 Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
6 Laboratory of Biostatistics, Clinical Research and Epidemiology, Department of Public Health, Mohamed V University, Rabat, Morocco
7 Department of Cardiology B, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
8 Nephrology-Dialysis-Renal Transplantation Department, Ibn Sina University Hospital, Mohamed V University, Rabat, Morocco
Introduction: Cardio-renal syndrome (CRS) is a complex pathophysiological entity affecting the heart and kidneys in which acute or chronic dysfunction of one organ can induce acute or chronic dysfunction of the other organ. Five types of CRS have been described. Methods: The study explored the prevalence and types of Cardiorenal Syndrome (CRS) at Ibn Sina University Hospital of Rabat. Over a year, 120 CRS patients were assessed, excluding those with end-stage chronic renal failure. We analyzed the epidemiological, clinical, therapeutic and evolutionary profile of these patients. Results: The average age of our patients is 67.8 ± 12 years, with extremes ranging from 39 years to 92 years. The sex ratio is 1.35. The different types of CRS types (1, 2, 4 and 5) were noted respectively in 28.4%, 20.8%, 5%, 45.8%, however, we did not note patients having CRS type 3. On the renal level, we noted acute renal failure (ARF) in 51.6% of patients, of whom 61.3% had functional ARF and 38.7% presented with acute tubular necrosis. Chronic renal failure (CRF) is found in 48.4% of cases, of which 39% are at stage III and 61% are at stage IV. The etiology of CKD is dominated by hypertensive nephropathy (72.4%) followed by diabetic nephropathy (60.3%). Therapeutically diuretics are administered in 51% of our patients. We used hemodialysis in 9.1% of patients who are resistant to diuretics. Vasoactive drugs are used in 9.5% of our patients. Mortality risk factors for patients with CRS are significantly related to advanced age, long hospital stay, type 1 CRS, re-hospitalization, acute pulmonary edema (APE), use of hemodialysis, right heart failure (RHF), valvulopathy and hemodynamic instability (OR = 1.15, p = 0.01; OR = 4.5, p = 0.03; OR = 5.2, p = 0.019; p < 0.01; OR = 2.7, p = 0.023; p = 0.018, OR = 14.12; p = 0.046, OR = 14.53; p = 0.009; OR = 20.06, p = 0.002, respectively). Re-hospitalization is significantly correlated with profound anemia in multivariate analysis (p ≤ 0.01). Conclusion: CRS type 5 was most common, with hypertension and diabetes being primary causes of Chronic Kidney Disease. Mortality factors were linked to acute pulmonary edema, hemodialysis, right heart failure, valvulopathy, and re-hospitalization
Michel, T., et al. (2018) Le syndrome cardio-rénal. Anesthésie & Réanimation, 4, 386-396. https://doi.org/10.1016/j.anrea.2018.07.005
House, A.A., Anand, I., Bellomo, R., Cruz, D., Bobek, I., Anker, S.D., et al. (2010) Definition and Classification of Cardio-Renal Syndromes: Workgroup Statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation, 25, 1416-1420. https://doi.org/10.1093/ndt/gfq136
Goursaud, S. and Cheyron, D. (2014) Le syndrome cardiorénal: Diagnostic, physiopathologie et prise en charge. Réanimation, 23, 585-594. https://doi.org/10.1007/s13546-014-0897-6
Makris, K. and Spanou, L. (2016) Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clinical Biochemist Reviews, 37, 85-98.
Livio, F., et al. (2008) Estimation de la fonction rénale par l’équation MDRD: Intérêt et limites pour l’adaptation des doses de médicaments. Revue Médicale Suisse, 4, 2596-2600.
McDonagh, T., et al. (2021) Lignes directrices ESC 2021 pour le diagnostic et le traitement de l’insuffisance cardiaque aiguë et chronique. European Heart Journal, 42, 3599-3726.
Vincent, J.L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., et al. (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. Journal of the American Medical Association, 302, 2323-2329. https://doi.org/10.1001/jama.2009.1754
Walkey, A.J., Wiener, R.S. and Lindenauer, P.K. (2013) Utilization Patterns and Outcomes Associated with Central Venous Catheter in Septic Shock: A Population-Based Study. Critical Care Medicine, 41, 1450-1457. https://doi.org/10.1097/CCM.0b013e31827caa89
Jaccard, A., Desport, E., Mohty, D. and Bridoux, F. (2015) Amylose AL. La Revue de Médecine Interne, 36, 89-97. https://doi.org/10.1016/j.revmed.2014.08.003
Falk, R.H., Comenzo, R.L. and Skinner, M. (1997) The Systemic Amyloidoses. The New England Journal of Medicine, 337, 898-909. https://doi.org/10.1056/NEJM199709253371306
Saba, M., Tohmé, A., Abadjian, G., Haddad, F. and Gbayad, E. (2005) Amyloses multisystémiques: étude clinique de 39 patients au Liban. La Presse Médicale, 34, 640-646. https://doi.org/10.1016/S0755-4982(05)84002-3
Gratteau, G., Benson, M.D. and Delpech, M. (2008) Les amyloses. Flammarion, Paris, 345-365.
Bziz, A., Rouas, L., Lamalmi, N., Malihy, A., Cherradi, N., Ouzeddoun, N., et al. (2015) Amyloses rénales AA: Corrélations anatomocliniques dans une série marocaine de 30 cas. Néphrologie & Thérapeutique, 11, 543-550. https://doi.org/10.1016/j.nephro.2015.06.007
Aucouturier, P., Ronco, P. and Preud’Homme, J.L. (2000) Amylose Immunoglobulinique. In: Grateau, G., Merill, D., Benson, D. and Delpech, M., Eds., Les amylases, Flammarion Médecine, Paris, 341-376.
Isabel, C., Gerogin-Lavialle, S., Aouba, A., Delarue, R., Nochy, D., Karras, A., et al. (2013) Amylose cardiaque: à propos d’une série de 14 patients, description et facteurs pronostiques. La Revue de Médecine Interne, 34, 671-678. https://doi.org/10.1016/j.revmed.2013.05.003
Dar, O. and Cowie, M.R. (2008) Acute Heart Failure in the Intensive Care Unit: Epidemiology. Critical Care Medicine, 36, S3-S8. https://doi.org/10.1097/01.CCM.0000296264.41365.80
Bagshaw, S.M., Cruz, D.N., Aspromonte, N., Daliento, L., Ronco, F., Sheinfeld, G., et al. (2010) Epidemiology of Cardio-Renal Syndromes: Workgroup Statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation, 25, 1406-1416. https://doi.org/10.1093/ndt/gfq066
Vandenberghe, W., Gevaert, S., Kellum, J.A., Bagshaw, S.M., Peperstraete, H., Herck, I., et al. (2016) Acute Kidney Injury in Cardiorenal Syndrome Type 1 Patients: A Systematic Review and Meta-Analysis. Cardiorenal Medicine, 6, 116-128. https://doi.org/10.1159/000442300
Hillege, H.L., Nitsch, D., Pfeffer, M.A., et al. (2006) Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients with Heart Failure. Circulation, 113, 671-678. https://doi.org/10.1161/CIRCULATIONAHA.105.580506
Culleton, B.F., Larson, M.G., Wilson, P.W., et al. (1999) Cardiovascular Disease and Mortality in a Community-Based Cohort with Mild Renal Insufficiency. Kidney International, 56, 2214-2219. https://doi.org/10.1046/j.1523-1755.1999.00773.x
Brown, J.H., Hunt, L.P., Vites, N.P., Short, C.D., Gokal, R. and Mallick, N.P. (1994) Comparative Mortality from Cardiovascular Disease in Patients with Chronic Renal Failure. Nephrology Dialysis Transplantation, 9, 1136-1142. https://doi.org/10.1093/ndt/9.8.1136
Neaton, J.D. and Wentworth, D. (1992) Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death from Coronary Heart Disease. Overall Findings and Differences by Age for 316099 White Men. The Archives of Internal Medicine, 152, 56-64. https://doi.org/10.1001/archinte.1992.00400130082009
Zager, P.G., Nikolic, J., Brown, R.H., et al. (1998) “U” Curve Association of Blood Pressure and Mortality in Hemodialysis Patients. Kidney International, 54, 561-569. https://doi.org/10.1046/j.1523-1755.1998.00005.x
Go, A.S., Chertow, G.M., Fan, D., McCulloch, C.E. and Hsu, C.Y. (2004) Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. The New England Journal of Medicine, 351, 1296-1305. https://doi.org/10.1056/NEJMoa041031
Hage, F.G., Venkataraman, R., Zoghbi, G.J., Perry, G.J., DeMattos, A.M. and Iskandrian, A.E. (2009) The Scope of Coronary Heart Disease in Patients with Chronic Kidney Disease. Journal of the American College of Cardiology, 53, 2129-2140. https://doi.org/10.1016/j.jacc.2009.02.047
Silberberg, J., Racine, N., Barre, P. and Sniderman, A.D. (1990) Regression of Left Ventricular Hypertrophy in Dialysis Patients following Correction of Anemia with Recombinant Human Erythropoietin. Canadian Journal of Cardiology, 6, 1-4.
Schrier, R., McFann, K., Johnson, A., et al. (2002) Cardiac and Renal Effects of Standard versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycystic Kidney Disease: Results of a Seven-Year Prospective Randomized Study. Journal of the American Society of Nephrology, 13, 1733-1739. https://doi.org/10.1097/01.ASN.0000018407.60002.B9
London, G. (1998) Heterogeneity of Left Ventricular Hypertrophy. Does It Have Clinical Implications? Nephrology Dialysis Transplantation, 13, 17-19. https://doi.org/10.1093/ndt/13.1.17
Al-Ahmad, A., Rand, W.M., Manjunath, G., et al. (2001) Reduced Kidney Function and Anemia as Risk Factors for Mortality in Patients with Left Ventricular Dysfunction. Journal of the American College of Cardiology, 38, 955-962. https://doi.org/10.1016/S0735-1097(01)01470-X
Silverberg, D.S., Wexler, D., Blum, M., et al. (2002) The Correction of Anemia in Severe Resistant Heart Failure with Erythropoietin and Intravenous Iron Prevents the Progression of Both the Heart and the Renal Failure and Markedly Reduces Hospitalization. Clinical Nephrology, 58, S37-S45.
Silverberg, D.S., Wexler, D., Blum, M., et al. (2001) Aggressive Therapy of Congestive Heart Failure and Associated Chronic Renal Failure with Medications and Correction of Anemia Stops or Slows the Progression of Both Diseases. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 21, S236-S240. https://doi.org/10.1177/089686080102103S42
Kates, D.M., Sherrard, D.J. and Andress, D.L. (1997) Evidence That Serum Phosphate Is Independently Associated with Serum PTH in Patients with Chronic Renal Failure. American Journal of Kidney Diseases, 30, 809-813. https://doi.org/10.1016/S0272-6386(97)90086-X
Koenig, K.G., Lindberg, J.S., Zerwekh, J.E., et al. (1992) Free and Total 1, 25-Dihydroxyvitamin D Levels in Subjects with Renal Disease. Kidney International, 4, 161-165. https://doi.org/10.1038/ki.1992.22
Jacob, C., Jentzer, M.D., et al. (2020) Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives. Journal of the American College of Cardiology, 76, 1084-1101. https://doi.org/10.1016/j.jacc.2020.06.070
Costanzo, M.R., Negoianu, D., Jaski, B.E., et al. (2016) Aquapheresis versus Intravenous Diuretics and Hospitalizations for Heart Failure. JACC: Heart Failure, 4, 95-105. https://doi.org/10.1016/j.jchf.2015.08.005
Bart, B.A., Goldsmith, S.R., Lee, K.L., et al. (2012) Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome. The New England Journal of Medicine, 367, 2296-2304. https://doi.org/10.1056/NEJMoa1210357
Michael Felker, G., et al. (2011) Diuretic Strategies in Patients with Acute Decompensated Heart Failure. The New England Journal of Medicine, 364, 797-805. https://doi.org/10.1056/NEJMoa1005419
Costanzo, M.R., Negoianu, D., et al. (2015) Aquapheresis versus Intravenous Diuretics and Hospitalizations for Heart Failure. JACC: Heart Fail, 4, 95-105.
Berger, C., et al. (2020) Patients with Acute Heart Failure Treated with the CARRESS-HF Diuretic Protocol in Association with Canrenoate Potassium: Tolerance of High Doses of Canrenoate Potassium. Archives of Cardiovascular Diseases, 113, 679-689. https://doi.org/10.1016/j.acvd.2020.05.017
Wang, M.J., Zheng, Y.M. and Jin, H.X. (2021) Ultrafiltration for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis. Medicine, 100, e28029. https://doi.org/10.1097/MD.0000000000028029
Ronco, C. and Di Lullo, L. (2017) Cardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches. Kidney Diseases, 2, 151-163. https://doi.org/10.1159/000448749